Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Здрава оценка на контрафактуалното въздействие× | Съгласуване по показател на склонност× | |
|---|---|---|
| Област≠ | Причинно-следствено заключение | Статистика за изследвания |
| Семейство≠ | Regression model | Process / pipeline |
| Година на възникване≠ | 2010s | 1983 |
| Създател≠ | European Commission evaluation community; Pellegrini, Ferrara and colleagues | Paul Rosenbaum and Donald Rubin |
| Тип≠ | Robustness-validated causal evaluation | Method |
| Основополагащ източник≠ | Bia, M., Flores, C. A., Flores-Lagunes, A., & Mattei, A. (2014). A Stata package for the application of semiparametric estimators of dose–response functions. Stata Journal, 14(3), 580–604. link ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Други названия≠ | Robust CIE, Sensitivity-checked CIE, Multi-method counterfactual evaluation, Robustness-validated impact evaluation | PSM, propensity score weighting, covariate balance |
| Свързани≠ | 5 | 3 |
| Резюме≠ | Robust Counterfactual Impact Evaluation (Robust CIE) strengthens causal impact estimates by combining multiple quasi-experimental estimators, placebo tests, and formal sensitivity analyses. Rather than relying on a single method, it cross-validates findings across approaches — such as matching, difference-in-differences, and regression discontinuity — to ensure that conclusions do not depend on any single methodological choice. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateНабор от данни ↗ |
|
|